Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Related Concept Videos

You might also read

Related Articles

Articles linked to this work by shared authors, journal, and citation graph.

Sort by
Same author

Editorial for "Non-enhanced Chemical Exchange Saturation Transfer Cardiac Magnetic Resonance Imaging in Patients With Amyloid Light Chain Amyloidosis".

Journal of magnetic resonance imaging : JMRI·2021
Same author

Initial investigation of a novel noninvasive weight loss therapy using MRI-Guided high intensity focused ultrasound (MR-HIFU) of visceral fat.

Magnetic resonance in medicine·2015
Same author

Imaging of brain tumors with paramagnetic vesicles targeted to phosphatidylserine.

Journal of magnetic resonance imaging : JMRI·2014
Same author

Molecular MR imaging of neovascular progression in the Vx2 tumor with αvβ3-targeted paramagnetic nanoparticles.

Radiology·2013
Same author

An MRI system for imaging neonates in the NICU: initial feasibility study.

Pediatric radiology·2012
Same author

Magnetic resonance chemical exchange saturation transfer imaging and nanotechnology.

Wiley interdisciplinary reviews. Nanomedicine and nanobiotechnology·2012

Related Experiment Video

Updated: Apr 27, 2026

Biofunctionalized Prussian Blue Nanoparticles for Multimodal Molecular Imaging Applications
11:28

Biofunctionalized Prussian Blue Nanoparticles for Multimodal Molecular Imaging Applications

Published on: April 28, 2015

9.7K

Perfluorocarbon nanoparticles: evolution of a multimodality and multifunctional imaging agent.

Patrick M Winter1

  • 1Department of Radiology, Cincinnati Children's Hospital, Cincinnati, OH 45229, USA.

Scientifica
|July 16, 2014
PubMed
Summary

Perfluorocarbon nanoparticles provide a safe and stable platform for advanced molecular imaging and targeted drug delivery. These nanoparticles can be customized to detect disease biomarkers and deliver therapeutics, improving patient care for various conditions.

More Related Videos

Biomolecular Imaging of Cellular Uptake of Nanoparticles using Multimodal Nonlinear Optical Microscopy
07:13

Biomolecular Imaging of Cellular Uptake of Nanoparticles using Multimodal Nonlinear Optical Microscopy

Published on: May 16, 2022

1.8K
Formulation and Acoustic Modulation of Optically Vaporized Perfluorocarbon Nanodroplets
07:44

Formulation and Acoustic Modulation of Optically Vaporized Perfluorocarbon Nanodroplets

Published on: July 16, 2021

2.1K

Related Experiment Videos

Last Updated: Apr 27, 2026

Biofunctionalized Prussian Blue Nanoparticles for Multimodal Molecular Imaging Applications
11:28

Biofunctionalized Prussian Blue Nanoparticles for Multimodal Molecular Imaging Applications

Published on: April 28, 2015

9.7K
Biomolecular Imaging of Cellular Uptake of Nanoparticles using Multimodal Nonlinear Optical Microscopy
07:13

Biomolecular Imaging of Cellular Uptake of Nanoparticles using Multimodal Nonlinear Optical Microscopy

Published on: May 16, 2022

1.8K
Formulation and Acoustic Modulation of Optically Vaporized Perfluorocarbon Nanodroplets
07:44

Formulation and Acoustic Modulation of Optically Vaporized Perfluorocarbon Nanodroplets

Published on: July 16, 2021

2.1K

Area of Science:

  • Nanotechnology
  • Biomedical Engineering
  • Materials Science

Background:

  • Perfluorocarbon nanoparticles (PFPNs) are biologically inert, stable, and nontoxic.
  • PFPNs can be functionalized for targeted molecular imaging and drug delivery in vivo.
  • Their versatility addresses challenges in diagnosing and treating complex diseases.

Purpose of the Study:

  • To highlight the potential of PFPNs as a dual-function platform for molecular imaging and drug delivery.
  • To demonstrate the adaptability of PFPNs for targeting disease-specific biomarkers.
  • To showcase the application of PFPNs in preclinical models for various debilitating diseases.

Main Methods:

  • Surface modification of PFPNs with targeting ligands.
  • Incorporation of diverse imaging agents (e.g., MRI contrast agents, radionuclides, iodine, fluorescent tags).
  • Co-delivery of potent therapeutic drugs with imaging capabilities.

Main Results:

  • Targeted delivery of PFPNs to disease biomarkers in animal models.
  • High-sensitivity detection of low-expressed cellular receptors using various imaging modalities.
  • Effective drug deposition in diseased cells, demonstrating therapeutic potential.
  • Demonstrated efficacy in preclinical models for cancer, cardiovascular disease, obesity, and thrombosis.

Conclusions:

  • PFPNs represent a highly flexible and robust platform for combined molecular imaging and drug delivery.
  • This dual-modality approach shows significant promise for improving the diagnosis and treatment of major diseases.
  • Further development and application of PFPNs could revolutionize patient care for debilitating conditions.